Literature DB >> 30032747

Mechanisms of Complement-Mediated Damage in Hematological Disorders.

Ronald P Taylor1, Margaret A Lindorfer2.   

Abstract

The complement cascade is an ancient defense system that destroys and eliminates threats to normal homeostasis in the bloodstream and tissues. Although multiple controls keep complement in check to minimize innocent bystander injury to normal cells and tissues, defects in complement regulation due to mutations in, or autoantibodies to, complement control proteins underlie the pathogenesis of several hemolytic diseases including paroxysmal nocturnal hemoglobinuria, and atypical hemolytic uremic syndrome. In autoimmune hemolytic anemias complement plays an important role in erythrocyte destruction mediated by antierythrocyte antibodies. The pathogenic mechanisms of these hemolytic diseases are discussed, with an emphasis on pivotal steps in complement activation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical Hemolytic Uremic Syndrome; Complement; Paroxysmal Nocturnal Hemoglobinuria

Mesh:

Substances:

Year:  2018        PMID: 30032747     DOI: 10.1053/j.seminhematol.2018.02.003

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  3 in total

1.  Classical complement activation on human erythrocytes in subjects with systemic lupus erythematosus and a history of autoimmune hemolytic anemia.

Authors:  Pamela Hair; Daniel W Goldman; Jessica Li; Michelle Petri; Neel Krishna; Kenji Cunnion
Journal:  Lupus       Date:  2020-07-12       Impact factor: 2.911

Review 2.  Halting targeted and collateral damage to red blood cells by the complement system.

Authors:  M Jalink; E C W de Boer; D Evers; M Q Havinga; J M I Vos; S Zeerleder; M de Haas; I Jongerius
Journal:  Semin Immunopathol       Date:  2021-06-30       Impact factor: 9.623

3.  Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria

Authors:  Antonio M Risitano; Austin G Kulasekararaj; Jong Wook Lee; Jaroslaw P Maciejewski; Rosario Notaro; Robert Brodsky; Mingjun Huang; Michael Geffner; Peter Browett
Journal:  Haematologica       Date:  2021-12-01       Impact factor: 9.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.